第三季度,美国生物科技市场的多项关键指标纷纷回升,这引发了一个疑问:我们是否终于看到了复苏的初步迹象,还是又一次的假象?典型例证包括,过去六个月,纳斯达克生物科技指数(XBI)稳步上涨,上月末成功突破100美元大关。美联储也采取了行动,将利率下调25个基点,这一举措让市场重燃希望——长期借贷成本下降的趋势预计将在未来几个月为生物科技行业注入强劲动力。DealForma公司负责人克里斯·多科马吉拉尔...
Source Link第三季度,美国生物科技市场的多项关键指标纷纷回升,这引发了一个疑问:我们是否终于看到了复苏的初步迹象,还是又一次的假象?典型例证包括,过去六个月,纳斯达克生物科技指数(XBI)稳步上涨,上月末成功突破100美元大关。美联储也采取了行动,将利率下调25个基点,这一举措让市场重燃希望——长期借贷成本下降的趋势预计将在未来几个月为生物科技行业注入强劲动力。DealForma公司负责人克里斯·多科马吉拉尔...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.